Protein kinases: Receptors of external signals

Journal of Clinical Ligand Assay

Volumn 23, Issue 1, 2000, Pages 50-56

  Cooper, D R ^a   Hanson Painton, O ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Gene expression; Protein kinases; RNA processing; Signal transduction

Indexed keywords

PROTEIN KINASE;

ARTICLE; CELLULAR DISTRIBUTION; DEPHOSPHORYLATION; DROSOPHILA; GENE EXPRESSION REGULATION; NONHUMAN; RNA PROCESSING; SIGNAL TRANSDUCTION;

EID: 0033678602     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase
2. Protein kinases 6. The eukaryotic protein kinase superfamily: Kinase (catalytic) domain structure and classification
3. How do protein kinases recognize their substrates?
4. Localization of protein kinases by anchoring proteins: A theme in signal transduction
5. The roles of 14-3-3 proteins in signal transduction
6. Structural and functional basis for hormone binding and receptor oligomerization
7. Emodin, a protein tyrosine kinase inhibitor from polygonum cuspidatum
8. Src-related protein tyrosine kinases and their surface receptors
9. Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus
10. I kappa B: A specific inhibitor of the NF-kappa B transcription factor
11. In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C
12. Regulation of alternative splicing of protein kinase C beta by insulin
13. Identification of two essential phosphorylated threonine residues in the catalytic domain of Mekk1. Indirect activation by Pak3 and protein kinase C
14. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis
15. Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes
16. Protein kinase C-delta mRNA is down-regulated transcriptionally and post-transcriptionally by 12-O-tetradecanoylphorbol-13-acetate
17. Acute hyperglycemia regulates transcription and post-transcriptional stability of PKCbetaII mRNA in vascular smooth muscle cells
18. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor
19. Characterization and differential expression of protein kinase C isoforms in PC12 cells. Differentiation parallels an increase in PKC beta II
20. Protein phosphorylation in apoptosis
21. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region
22. Insulin, but not contraction, activates Akt/PKB in isolated rat skeletal muscle
23. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin
24. Protein kinase C: Structure, function, and regulation
25. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors
26. Calphostins (UCN-1028), novel and specific inhibitors of protein kinase C. I. Fermentation, isolation, physico-chemical properties and biological activities
27. Calphostins, novel and specific inhibitors of protein kinase C. II. Chemical structures
28. Chelerythrine is a potent and specific inhibitor of protein kinase C
29. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
30. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C
31. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives
32. 2+ activated, phospholipid-dependent and other protein kinases
33. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthe-sized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells
34. Role of protein kinase A in LPS-induced activation of NF-kappa B proteins of a mousemacrophage-like cell line, J774
35. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases
36. K252a, a new inhibitor of protein kinase C, concomitantly inhibits 40K protein phosphorylation and serotonin secretion in a phorbol ester-stimulated platelets
37. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II
38. Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase
39. ++dependent protein kinase
40. Staurosporine, a protein kinase C inhibitor interferes with proliferation of arterial smooth muscle cells
41. Staurosporine: An effective inhibitor for Ca2+/calmodulin-dependent protein kinase II
42. Staurosporine inhibits a tyrosine protein kinase in human hepatoma cell membranes
43. Reactive oxygen species are involved in the activation of cellular phospholipase A2
44. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976
45. Phosphorylation of protein kinase Cdelta (PKCdelta) at threonine 505 is not a prerequisite for enzymatic activity. Expression of rat PKCdelta and an alanine 505 mutant in bacteria in a functional form
46. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes
47. Rottlerin, a novel protein kinase inhibitor
48. New hexahydroxybiphenyl derivatives as inhibitors of protein kinase C
49. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor
50. A carboxy-terminal deletion mutant of protein kinase C beta II inhibits insulin-stimulated 2-deoxyglucose uptake in L6 rat skeletal muscle cells
51. Genistein, a specific inhibitor of tyrosine-specific protein kinases
52. Thiazolidine-diones-Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors
53. Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages
54. Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells
55. Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus
56. Tyrphostins as molecular tools and potential antiproliferative drugs
57. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors
58. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling
59. Factors affecting the activity of muscle phosphorylase b kinase